Home / Data / Women's Health Trial Tracker Women's Health Trial Tracker Women's Health Trial Tracker organizes records from ClinicalTrials.gov API v2 into a static table for transparent comparison. It preserves official source links and dates, marks missing enrichment, and adds deterministic grouping, change, recency, trend, or significance fields only where the documented inputs support them, without recommendations or unsupported claims.
Records 5,000
Last changed 08/26/2026
Update schedule 55 1 * * * UTC
Coverage 05/26/2000–08/25/2026 Record Record Date Vuga Group Change Status Recency Days Public Significance Score Estrogen and Microvascular Function 09/21/2023 OBSERVATIONAL unchanged 1,070.85 0 Evaluation of the SafeSpace App Intervention 09/21/2023 INTERVENTIONAL unchanged 1,070.85 0 Efficacy of Injectable Vitamin D Supplementation in Females With Polycystic Ovary Syndrome 09/21/2023 INTERVENTIONAL unchanged 1,070.85 0 Early Diagnosis of Breast Cancer-related Lymphedema 09/21/2023 OBSERVATIONAL unchanged 1,070.85 0 Macronutrients in Lactating NICU Parents - Impact of Kangaroo Care 09/21/2023 INTERVENTIONAL unchanged 1,070.85 0 Multidisciplinary Diagnosis and Treatment of Polycystic Ovary Syndrome 09/21/2023 OBSERVATIONAL unchanged 1,070.85 0 Circulating Tumour Cells Characterization in Breast Cancer Patients 09/21/2023 OBSERVATIONAL unchanged 1,070.85 0 Maternal Mental Health Access - MaMa 09/22/2023 INTERVENTIONAL unchanged 1,069.85 0 Prelabor Visual Biofeedback by a Self-operated Ultrasound Device 09/22/2023 INTERVENTIONAL unchanged 1,069.85 0 Maternal And Infant Antipsychotic Study 09/22/2023 OBSERVATIONAL unchanged 1,069.85 0 The Benefits of Continued Use of Ovarian Function Suppression After 5 Years 09/22/2023 OBSERVATIONAL unchanged 1,069.85 0 Roadmap to Parenthood: Testing the Efficacy of a Decision Aid and Planning Tool for Family Building After Cancer 09/22/2023 INTERVENTIONAL unchanged 1,069.85 0 Faecal Microbiota Transplantation as Means of Preventing Recurrent Urinary Tract Infections 09/22/2023 INTERVENTIONAL unchanged 1,069.85 0 Glucose Evaluation Through Continuous Glucose Monitors in Polycystic Ovary Syndrome 09/22/2023 INTERVENTIONAL unchanged 1,069.85 0 Innovation for Small-scale Experiments: ReceptIVFity Test 09/22/2023 INTERVENTIONAL unchanged 1,069.85 0 Comparison of 5-ALA Photodynamic Therapy and CO2 Laser for Treating Persistent Low-Grade Cervical Lesions With High-Risk HPV Infection 09/25/2023 INTERVENTIONAL unchanged 1,066.85 0 Strength After Breast Cancer 09/25/2023 INTERVENTIONAL unchanged 1,066.85 0 SAHARA-04 : Adaptive Radiotherapy in Hypersensitive Patients and High Locoregional Risk Breast Cancer With ETHOS Technology 09/25/2023 INTERVENTIONAL unchanged 1,066.85 0 Is the Vaginal Microbiome and Metabolome Associated With Spontaneous Preterm Birth (sPTB) in Multiple Pregnancies? 09/26/2023 OBSERVATIONAL unchanged 1,065.85 0 An Observational Study to Learn About the Interferon-beta Exposure of Pregnant Women During the Second and Third Trimester in Finland and Sweden 09/26/2023 OBSERVATIONAL unchanged 1,065.85 0 Non-Invasive Brain Stimulation and Cognitive Training for Depressive Symptomatology Related to Breast Cancer (ONCODEP) 09/26/2023 INTERVENTIONAL unchanged 1,065.85 0 Zimberelimab Combined With Albumin-bound Paclitaxel and Cisplatin in Neoadjuvant Treatment of LACC 09/28/2023 INTERVENTIONAL unchanged 1,063.85 0 Primary Breast Oligoprogressive Sites Treated With Radiotherapy to Obviate the Need to Change Systemic Therapy 09/28/2023 INTERVENTIONAL unchanged 1,063.85 0 A Prospective Study on the Role of Karl Storz Curved and Straight Fetoscopes (11508AAK and 11506AAK) for Fetoscopic Intrauterine Procedures 09/28/2023 INTERVENTIONAL unchanged 1,063.85 0 A Phase III Study of SHR-A1811 Injection With or Without Pertuzumab in HER2-Positive Recurrent or Metastatic Breast Cancer 09/28/2023 INTERVENTIONAL unchanged 1,063.85 0 Molecular Breast Imaging Guidance for Breast Biopsy for Patients With Breast Abnormalities 09/28/2023 INTERVENTIONAL unchanged 1,063.85 0 Ecological Momentary Breastfeeding Intervention 09/28/2023 INTERVENTIONAL unchanged 1,063.85 0 The Optimised Use of Romozosumab Study 09/28/2023 INTERVENTIONAL unchanged 1,063.85 0 Digital Breast Tomosynthesis for the Dutch National Breast Cancer Screening Program 09/28/2023 INTERVENTIONAL unchanged 1,063.85 0 PSMA-PET/CT to Assess the Expression of Specific Membrane Antigen (PSMA) in Patients With Progressive Triple-negative Breast Cancer. 09/28/2023 INTERVENTIONAL unchanged 1,063.85 0 Pre-Rehabilitation for Female Patients Undergoing Pelvic Radiotherapy 09/28/2023 INTERVENTIONAL unchanged 1,063.85 0 The Effects of Metabolic & Bariatric Surgery on Lipid Metabolism, Myeloid-Derived Suppressor Cells, and Cancer Cell Biology 09/28/2023 OBSERVATIONAL unchanged 1,063.85 0 Personalized Breast Cancer Screening 09/29/2023 INTERVENTIONAL unchanged 1,062.85 0 Mobile Instant Messaging-based Lifestyle Intervention for Gestational Diabetes Prevention 09/29/2023 INTERVENTIONAL unchanged 1,062.85 0 Bioequivalence ANDA SNP Clinical Study - Raloxifene and Single Nucleotide Polymorphisms 10/02/2023 INTERVENTIONAL unchanged 1,059.85 0 RC48 Combined With Tislelizumab for Second-line Treatment of HER2 Expression in Recurrent Cervical Cancer 10/02/2023 INTERVENTIONAL unchanged 1,059.85 0 Effect of Metformin on Healthy Live Birth in Women With Prediabetes 10/03/2023 INTERVENTIONAL unchanged 1,058.85 0 A Phase I/II Study of FWD1802 in Patients With ER+/HER2- Advanced BC. 10/03/2023 INTERVENTIONAL unchanged 1,058.85 0 Ovarian Tumor Organotypic Slices Cultures for functionAl Drug Testing and Therapy Response Prediction 10/03/2023 INTERVENTIONAL unchanged 1,058.85 0 A Multicenter Observational Study on the Development and Health Effects of Premature Ovarian Insufficiency 10/05/2023 OBSERVATIONAL unchanged 1,056.85 0 Kidney and Pregnancy Registry 10/05/2023 OBSERVATIONAL unchanged 1,056.85 0 Weight Loss Following an Episode of Pre-eclampsia Using a Dissociated or Hypocaloric Diet in Overweight or Obese Patients 10/05/2023 INTERVENTIONAL unchanged 1,056.85 0 Classifying for HER2 Dependence to De-Escalate Neoadjuvant Chemotherapy in Patients With HER2+ Early Breast Cancer Undergoing HER2 Double-Blockade 10/05/2023 INTERVENTIONAL unchanged 1,056.85 0 Radiotherapy Exposed Lung Injury: Effect on Functioning - Cohort 10/05/2023 OBSERVATIONAL unchanged 1,056.85 0 Effect of Lactobacillus Johnsonii or White Pomegranate Extract on the Vaginal Health 10/05/2023 INTERVENTIONAL unchanged 1,056.85 0 Multiple Micronutrient Supplementation (MMS) Iron Dose Acceptability Crossover Trial 10/06/2023 INTERVENTIONAL unchanged 1,055.85 0 Prospective Evaluation of Infectious Vulvovaginitis on Wound Complication Rates After Vulvar Excision for Premalignant Lesions 10/06/2023 INTERVENTIONAL unchanged 1,055.85 0 Preoperative Evaluation of 3D Reconstruction Tool for Nipple-sparing Mastectomy 10/06/2023 INTERVENTIONAL unchanged 1,055.85 0 SEQUENTIAL PROFILING OF TUMOR-DERIVED CIRCULATING CELL-FREE DNA (ctDNA) IN ADVANCED OVARIAN CANCER PATIENTS 10/06/2023 INTERVENTIONAL unchanged 1,055.85 0 Neuromodulating Cortical Regions Involved in Neurogenic Bladder in MS 10/10/2023 INTERVENTIONAL unchanged 1,051.85 0
Source U.S. National Library of Medicine, ClinicalTrials.gov API v2 · official record · retrieved 08/26/2026 · upstream last modified 08/26/2026
Licence United States government work; public domain unless the source record says otherwise. Source: U.S. National Library of Medicine
Required notice Study records are informational and do not provide diagnosis, treatment advice, or an assessment of individual risk. What we add We compute Vuga Group, Change Status, Recency Days, Public Significance Score using the documented compute method. · methodology